As more cybersecurity concerns continue to threaten our country, the U.S. Food and Drug Administration (FDA) has updated its guidance on how medical device makers can ensure their approved products are safe from cyberattacks and report any post-approval fixes. According to Law360, the FDA’s announcement adds to a prior document highlighting the dangers associated with medical device software. The agency also held a public workshop Jan. 20-21 at its Silver Spring, Md., campus to discuss how different sectors can work together and reduce risks with Internet-connected medical devices. The FDA is emphasizing the importance of post-approval vigilance due to the growing tactics used by ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.